Eric Assénat - Researcher Profile | RDL Research Database

Publications

2 shown

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy , Pascal Hammel , Mohamed Hebbar +29 more

Adjuvant therapy with a modified FOLFIRINOX regimen led to significantly longer survival than gemcitabine among patients with resected pancreatic cancer, at the expense of a hig...

2018 New England Journal of Medicine 2673 citations

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Andrew X. Zhu , Yoon‐Koo Kang , Chia‐Jui Yen +21 more

2019 The Lancet Oncology 1593 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,266
Institution: Centre Hospitalier Universitaire de Montpellier

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-8958-2793

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.